The effect of pre-transplant pain and chronic disease self-efficacy on quality of life domains in the year following hematopoietic stem cell transplantation
- PMID: 29124418
- PMCID: PMC5823743
- DOI: 10.1007/s00520-017-3947-6
The effect of pre-transplant pain and chronic disease self-efficacy on quality of life domains in the year following hematopoietic stem cell transplantation
Abstract
Purpose: Pain is common for hematopoietic stem cell transplant (HSCT) patients and may be experienced pre-transplant, acutely post-transplant, and for months or years following transplant. HSCT patients with persistent pain may be at risk for poor quality of life following transplant; however, the impact of pre-transplant pain on quality of life post-transplant is not well understood. Self-efficacy for chronic disease management is associated with quality of life among cancer patients and may impact quality of life for HSCT patients. The primary aim was to examine the effect of pre-transplant pain and self-efficacy on quality of life domains in the year following transplant.
Methods: One hundred sixty-six HSCT patients completed questionnaires providing information on pain, self-efficacy, and quality of life prior to transplant, at discharge, and 3-, 6-, and 12-months post-transplant as part of a longitudinal, observational study. Linear mixed modeling examined the trajectories of these variables and the effect of pre-transplant pain and self-efficacy on post-transplant quality of life.
Results: Pain and social and emotional quality of life remained stable in the year following transplant while self-efficacy and physical and functional quality of life improved. Pre-transplant pain was significantly related to lower physical well-being post-transplant. Lower pre-transplant self-efficacy was related to lower quality of life across all domains post-transplant.
Conclusion: Above and beyond the effect of pre-transplant pain, self-efficacy for managing chronic disease is important in understanding quality of life following transplant. Identifying patients with pain and/or low self-efficacy pre-transplant may allow for early intervention with self-management strategies.
Keywords: HSCT; Pain; Quality of life; Self-efficacy.
Conflict of interest statement
References
-
- Bhatia S, Ramsay NKC, Robison LL, Snyder D, Stein A, Forman SJ, Weisdorf DJ, Francisco L, Carter A, Sun C-L, Baker KS, Gurney JG, McGlave PB, Nademanee A, O’Donnell M. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood. 2007;110(10):3784–3792. doi: 10.1182/blood-2007-03-082933. - DOI - PMC - PubMed
-
- Cutler C. UpToDate. UpToDate; Waltham, MA: 2017. The approach to hematopoietic cell transplantation survivorship.
-
- Champlin R. Selection of Autologous or Allogeneic Transplantation. In: Kufe DW, Pollock RE, Weischselbaum RR, et al., editors. Cancer Medicine. 6th. BC Decker; Hamilton, ON: 2003.
-
- Niscola P, Romani C, Scaramucci L, Dentamaro T, Cupelli L, Tendas A, Piccioni D, Giovannini M, Tolu B, Cartoni C, Arcuri E, Perrotti A, Palumbo R, de Fabritiis P. Pain syndromes in the setting of haematopoietic stem cell transplantation for haematological malignancies. Bone Marrow Transplant. 2008;41(9):757–764. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical